122 related articles for article (PubMed ID: 27589568)
1. T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.
Beschel LM; Leu M; Reichardt SD; Rave-Fränk M; Schirmer MA; Stadelmann C; Canis M; Wolff HA; Reichardt HM
Oncotarget; 2016 Oct; 7(40):65902-65915. PubMed ID: 27589568
[TBL] [Abstract][Full Text] [Related]
2. High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.
Tehrany N; Kitz J; Rave-Fränk M; Lorenzen S; Li L; Küffer S; Hess CF; Burfeind P; Reichardt HM; Canis M; Beissbarth T; Wolff HA
Strahlenther Onkol; 2015 Jul; 191(7):566-72. PubMed ID: 25575976
[TBL] [Abstract][Full Text] [Related]
3. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
[TBL] [Abstract][Full Text] [Related]
4. Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinoma.
Martin D; Rödel F; von der Grün J; Rödel C; Fokas E
Radiother Oncol; 2020 Aug; 149():168-173. PubMed ID: 32417344
[TBL] [Abstract][Full Text] [Related]
5. Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer.
Schuler PJ; Harasymczuk M; Schilling B; Saze Z; Strauss L; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2013 Dec; 19(23):6585-96. PubMed ID: 24097865
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
[TBL] [Abstract][Full Text] [Related]
7. Persistently elevated soluble MHC class I polypeptide-related sequence A and transforming growth factor-β1 levels are poor prognostic factors in head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Chen JL; Chang CC; Huang YS; Kuo HY; Chen TY; Wang CW; Kuo SH; Lin YL
PLoS One; 2018; 13(8):e0202224. PubMed ID: 30096190
[TBL] [Abstract][Full Text] [Related]
8. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Acta Otolaryngol; 1999 Mar; 119(2):281-4. PubMed ID: 10320092
[TBL] [Abstract][Full Text] [Related]
10. Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma.
Krupar R; Hautmann MG; Pathak RR; Varier I; McLaren C; Gaag D; Hellerbrand C; Evert M; Laban S; Idel C; Sandulache V; Perner S; Bosserhoff AK; Sikora AG
Am J Pathol; 2018 Jan; 188(1):72-83. PubMed ID: 29107073
[TBL] [Abstract][Full Text] [Related]
11. Polyfunctionality of CD4
Doescher J; Jeske S; Weissinger SE; Brunner C; Laban S; Bölke E; Hoffmann TK; Whiteside TL; Schuler PJ
Strahlenther Onkol; 2018 May; 194(5):392-402. PubMed ID: 29663037
[TBL] [Abstract][Full Text] [Related]
12. A preliminary investigation of circulating extracellular vesicles and biomarker discovery associated with treatment response in head and neck squamous cell carcinoma.
Rodrigues-Junior DM; Tan SS; de Souza Viana L; Carvalho AL; Lim SK; Iyer NG; Vettore AL
BMC Cancer; 2019 Apr; 19(1):373. PubMed ID: 31014274
[TBL] [Abstract][Full Text] [Related]
13. CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer.
Pandit R; Lathers DM; Beal NM; Garrity T; Young MR
Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):749-54. PubMed ID: 10961808
[TBL] [Abstract][Full Text] [Related]
14. An immunological outcome predictive score for head and neck carcinoma patients.
Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
[TBL] [Abstract][Full Text] [Related]
15. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer.
Pavón MA; Parreño M; León X; Sancho FJ; Céspedes MV; Casanova I; Lopez-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
Int J Cancer; 2008 Sep; 123(5):1068-79. PubMed ID: 18546291
[TBL] [Abstract][Full Text] [Related]
16. Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial.
Ghosh-Laskar S; Kalyani N; Gupta T; Budrukkar A; Murthy V; Sengar M; Chaukar D; Pai P; Chaturvedi P; D'Cruz A; Agarwal J
Head Neck; 2016 Feb; 38(2):202-7. PubMed ID: 25224814
[TBL] [Abstract][Full Text] [Related]
17. Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.
Shinoto M; Shioyama Y; Sasaki T; Nakamura K; Ohura H; Toh Y; Higaki Y; Yamaguchi T; Ohnishi K; Atsumi K; Hirata H; Honda H
Am J Clin Oncol; 2011 Aug; 34(4):362-6. PubMed ID: 20686402
[TBL] [Abstract][Full Text] [Related]
18. DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer.
Cirauqui B; Margelí M; Quiroga V; Quer A; Karachaliou N; Chaib I; Ramírez JL; Muñoz A; Pollán C; Planas I; Drozdowsky A; Rosell R
Tumour Biol; 2016 Oct; 37(10):13435-13443. PubMed ID: 27465548
[TBL] [Abstract][Full Text] [Related]
19. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Olofsson J
Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
